Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Carboplatin × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 186 Lung Neoplasms 67 Breast Neoplasms 52 Triple Negative Breast Neoplasms 51 Ovarian Neoplasms 50 Squamous Cell Carcinoma of Head and Neck 40 Fallopian Tube Neoplasms 34 Small Cell Lung Carcinoma 32 Endometrial Neoplasms 29 Neoplasms 28 Parkinson Disease 4, Autosomal Dominant Lewy Body 22 Prostatic Neoplasms 19 Neoplasm Metastasis 19 Head and Neck Neoplasms 19 Colorectal Neoplasms 18 Carcinoma 14 Uterine Cervical Neoplasms 13 Urinary Bladder Neoplasms 13 Oropharyngeal Neoplasms 12 Esophageal Neoplasms 12 Carcinoma, Squamous Cell 12 Esophageal Squamous Cell Carcinoma 11 Carcinoma, Transitional Cell 11 Pancreatic Neoplasms 10 Brain Neoplasms 10 Stomach Neoplasms 8 Mouth Neoplasms 8 Lung Diseases 8 Laryngeal Neoplasms 8 Advanced Solid Tumors 8

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡